Healio

Axpaxli meets superiority primary endpoint vs. aflibercept in wet AMD

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press ...
Healio

Eylea HD comparable to Eylea for long-term wet AMD control

Eylea HD injected every 12 or 16 weeks controls neovascular age-related macular degeneration to a similar extent as Eylea ...
bjo.bmj

Intravitreal bevacizumab (Avastin®) for macular oedema secondary to retinal vein occlusion: 12-month results of a prospective clinical trial

Aims: The aim of the study was to evaluate functional and anatomical changes after intravitreal bevacizumab (Avastin®) in eyes with persistent macular oedema secondary to branch retinal vein occlusion ...
bjo.bmj

Changes in choroidal structure following intravitreal aflibercept therapy for retinal vein occlusion

3 Department of Ophthalmology, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan Correspondence to Yoshinori Mitamura, Department of Ophthalmology, Institute of ...
The Washington Post

Should you drink bottled water or tap? The answer may surprise you.

I’ve been drinking bottled water but now I’m worried about microplastics. What’s the best choice here for my health? Bottled water often feels like a “healthier” choice — but there’s a problem, ...